Literature DB >> 24322617

Novel role of transient receptor potential vanilloid 2 in the regulation of cardiac performance.

Jack Rubinstein1, Valerie M Lasko, Sheryl E Koch, Vivek P Singh, Vinicius Carreira, Nathan Robbins, Amit R Patel, Min Jiang, Philip Bidwell, Evangelia G Kranias, W Keith Jones, John N Lorenz.   

Abstract

Transient receptor potential cation channels have been implicated in the regulation of cardiovascular function, but only recently has our laboratory described the vanilloid-2 subtype (TRPV2) in the cardiomyocyte, though its exact mechanism of action has not yet been established. This study tests the hypothesis that TRPV2 plays an important role in regulating myocyte contractility under physiological conditions. Therefore, we measured cardiac and vascular function in wild-type and TRPV2(-/-) mice in vitro and in vivo and found that TRPV2 deletion resulted in a decrease in basal systolic and diastolic function without affecting loading conditions or vascular tone. TRPV2 stimulation with probenecid, a relatively selective TRPV2 agonist, caused an increase in both inotropy and lusitropy in wild-type mice that was blunted in TRPV2(-/-) mice. We examined the mechanism of TRPV2 inotropy/lusitropy in isolated myocytes and found that it modulates Ca(2+) transients and sarcoplasmic reticulum Ca(2+) loading. We show that the activity of this channel is necessary for normal cardiac function and that there is increased contractility in response to agonism of TRPV2 with probenecid.

Entities:  

Keywords:  blood flow; blood pressure; calcium; cardiac myocytes; contractility; hemodynamics; ion channels; probenecid; vascular resistance

Mesh:

Substances:

Year:  2013        PMID: 24322617      PMCID: PMC3920243          DOI: 10.1152/ajpheart.00854.2013

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  24 in total

Review 1.  The history and future of probenecid.

Authors:  Nathan Robbins; Sheryl E Koch; Michael Tranter; Jack Rubinstein
Journal:  Cardiovasc Toxicol       Date:  2012-03       Impact factor: 3.231

2.  Translocation of a calcium-permeable cation channel induced by insulin-like growth factor-I.

Authors:  M Kanzaki; Y Q Zhang; H Mashima; L Li; H Shibata; I Kojima
Journal:  Nat Cell Biol       Date:  1999-07       Impact factor: 28.824

3.  TRPV2 is a component of osmotically sensitive cation channels in murine aortic myocytes.

Authors:  Katsuhiko Muraki; Yuko Iwata; Yuki Katanosaka; Tomohiro Ito; Susumu Ohya; Munekazu Shigekawa; Yuji Imaizumi
Journal:  Circ Res       Date:  2003-09-25       Impact factor: 17.367

Review 4.  Targeting TRPV1 and TRPV2 for potential therapeutic interventions in cardiovascular disease.

Authors:  Nathan Robbins; Sheryl E Koch; Jack Rubinstein
Journal:  Transl Res       Date:  2013-02-27       Impact factor: 7.012

5.  Nociceptors lacking TRPV1 and TRPV2 have normal heat responses.

Authors:  C Jeffery Woodbury; Melissa Zwick; Shuying Wang; Jeffrey J Lawson; Michael J Caterina; Martin Koltzenburg; Kathryn M Albers; H Richard Koerber; Brian M Davis
Journal:  J Neurosci       Date:  2004-07-14       Impact factor: 6.167

6.  Probenecid as a noninjurious positive inotrope in an ischemic heart disease murine model.

Authors:  Sheryl E Koch; Michael Tranter; Nathan Robbins; Kristin Luther; Umesh Singh; Min Jiang; Xiaoping Ren; Trisha Tee; Leah Smith; Priyanka Varma; W Keith Jones; Jack Rubinstein
Journal:  J Cardiovasc Pharmacol Ther       Date:  2012-12-14       Impact factor: 2.457

7.  Targeted ablation of the histidine-rich Ca(2+)-binding protein (HRC) gene is associated with abnormal SR Ca(2+)-cycling and severe pathology under pressure-overload stress.

Authors:  Chang Sik Park; Shan Chen; Hoyong Lee; Hyeseon Cha; Jae Gyun Oh; Sunghee Hong; Peidong Han; Kenneth S Ginsburg; Sora Jin; Inju Park; Vivek P Singh; Hong-Sheng Wang; Clara Franzini-Armstrong; Woo Jin Park; Donald M Bers; Evangelia G Kranias; Chunghee Cho; Do Han Kim
Journal:  Basic Res Cardiol       Date:  2013-04-04       Impact factor: 17.165

8.  Probenecid: novel use as a non-injurious positive inotrope acting via cardiac TRPV2 stimulation.

Authors:  Sheryl E Koch; Xiaoqian Gao; Lauren Haar; Min Jiang; Valerie M Lasko; Nathan Robbins; Wenfeng Cai; Cole Brokamp; Priyanka Varma; Michael Tranter; Yong Liu; Xiaoping Ren; John N Lorenz; Hong-Sheng Wang; W Keith Jones; Jack Rubinstein
Journal:  J Mol Cell Cardiol       Date:  2012-04-27       Impact factor: 5.000

9.  A TRPV2-PKA signaling module for transduction of physical stimuli in mast cells.

Authors:  Alexander J Stokes; Lori M N Shimoda; Murielle Koblan-Huberson; Chaker N Adra; Helen Turner
Journal:  J Exp Med       Date:  2004-07-12       Impact factor: 14.307

10.  A novel mechanism of myocyte degeneration involving the Ca2+-permeable growth factor-regulated channel.

Authors:  Yuko Iwata; Yuki Katanosaka; Yuji Arai; Kazuo Komamura; Kunio Miyatake; Munekazu Shigekawa
Journal:  J Cell Biol       Date:  2003-06-09       Impact factor: 10.539

View more
  27 in total

1.  Probenecid Inhibits α-Adrenergic Receptor-Mediated Vasoconstriction in the Human Leg Vasculature.

Authors:  Michael Nyberg; Peter Piil; Oliver T Kiehn; Christian Maagaard; Tue S Jørgensen; Jon Egelund; Brant E Isakson; Morten S Nielsen; Lasse Gliemann; Ylva Hellsten
Journal:  Hypertension       Date:  2017-10-30       Impact factor: 10.190

2.  Tsg101 positively regulates physiologic-like cardiac hypertrophy through FIP3-mediated endosomal recycling of IGF-1R.

Authors:  Kobina Essandoh; Shan Deng; Xiaohong Wang; Min Jiang; Xingjiang Mu; Jiangtong Peng; Yutian Li; Tianqing Peng; Kay-Uwe Wagner; Jack Rubinstein; Guo-Chang Fan
Journal:  FASEB J       Date:  2019-03-18       Impact factor: 5.191

3.  Transient receptor potential vanilloid-4 contributes to stretch-induced hypercontractility and time-dependent dysfunction in the aged heart.

Authors:  Adam B Veteto; Deborah Peana; Michelle D Lambert; Kerry S McDonald; Timothy L Domeier
Journal:  Cardiovasc Res       Date:  2020-09-01       Impact factor: 10.787

4.  Cardiovascular Risks of Probenecid Versus Allopurinol in Older Patients With Gout.

Authors:  Seoyoung C Kim; Tuhina Neogi; Eun Ha Kang; Jun Liu; Rishi J Desai; MaryAnn Zhang; Daniel H Solomon
Journal:  J Am Coll Cardiol       Date:  2018-03-06       Impact factor: 24.094

5.  Tranilast Blunts the Hypertrophic and Fibrotic Response to Increased Afterload Independent of Cardiomyocyte Transient Receptor Potential Vanilloid 2 Channels.

Authors:  Sheryl E Koch; Michelle L Nieman; Nathan Robbins; Samuel Slone; Mariah Worley; Lisa C Green; Yamei Chen; Alexandria Barlow; Michael Tranter; HongSheng Wang; John N Lorenz; Jack Rubinstein
Journal:  J Cardiovasc Pharmacol       Date:  2018-07       Impact factor: 3.105

6.  TRPA1 ion channel stimulation enhances cardiomyocyte contractile function via a CaMKII-dependent pathway.

Authors:  Spencer R Andrei; Monica Ghosh; Pritam Sinharoy; Souvik Dey; Ian N Bratz; Derek S Damron
Journal:  Channels (Austin)       Date:  2017-08-25       Impact factor: 2.581

Review 7.  Role of TRP channels in the cardiovascular system.

Authors:  Zhichao Yue; Jia Xie; Albert S Yu; Jonathan Stock; Jianyang Du; Lixia Yue
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-11-21       Impact factor: 4.733

8.  Axial stretch-dependent cation entry in dystrophic cardiomyopathy: Involvement of several TRPs channels.

Authors:  E Aguettaz; J J Lopez; B Constantin; S Sebille; A Krzesiak; L Lipskaia; S Adnot; R J Hajjar; C Cognard
Journal:  Cell Calcium       Date:  2016-01-06       Impact factor: 6.817

9.  Aryl Hydrocarbon Receptor Ablation in Cardiomyocytes Protects Male Mice From Heart Dysfunction Induced by NKX2.5 Haploinsufficiency.

Authors:  Qin Wang; Yunxia Fan; Hisaka Kurita; Min Jiang; Sheryl Koch; Marepalli B Rao; Jack Rubinstein; Alvaro Puga
Journal:  Toxicol Sci       Date:  2017-11-01       Impact factor: 4.849

10.  TRPV4 increases cardiomyocyte calcium cycling and contractility yet contributes to damage in the aged heart following hypoosmotic stress.

Authors:  John L Jones; Deborah Peana; Adam B Veteto; Michelle D Lambert; Zahra Nourian; Natalia G Karasseva; Michael A Hill; Brian R Lindman; Christopher P Baines; Maike Krenz; Timothy L Domeier
Journal:  Cardiovasc Res       Date:  2019-01-01       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.